Skip to content
The Policy VaultThe Policy Vault

Kineret — CareFirst (Caremark)

Deficiency of Interleukin-1 Receptor Antagonist (DIRA)

Initial criteria

  • Genetically confirmed deficiency of interleukin-1 receptor antagonist due to IL1RN gene variants

Approval duration

12 months